| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Relief Therapeutics Holding AG (OTCQB: RLFTF)
RLFTF Technical Analysis
3
| As on 14th Jan 2025 RLFTF STOCK Price closed @ 4.07 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.45 & Buy for SHORT-TERM with Stoploss of 3.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RLFTFSTOCK Price
| Open | 4.07 | Change | Price | % |
| High | 4.07 | 1 Day | -0.24 | -5.57 |
| Low | 4.07 | 1 Week | -2.51 | -38.15 |
| Close | 4.07 | 1 Month | 1.21 | 42.31 |
| Volume | 100 | 1 Year | -1.38 | -25.32 |
| 52 Week High 7.29 | 52 Week Low 1.10 | ||||
OTCQB USA Most Active Stocks
| FMCKJ | 9.73 | 0.83% |
| FNMA | 4.98 | 9.69% |
| BMIX | 0.01 | % |
| SILO | 1.80 | 4.65% |
| BTCWF | 0.10 | 150.00% |
| NNAX | 0.00 | % |
| XRTX | 1.27 | 1.60% |
| FMCC | 4.94 | 12.53% |
| EMED | 0.00 | % |
| SHMP | 0.00 | % |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| RLFTF Daily Charts |
RLFTF Intraday Charts |
Whats New @ Bazaartrend |
RLFTF Free Analysis |
|
|
RLFTF Important Levels Intraday
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
| RESISTANCE | 4.07 |
RLFTF Forecast January 2025
| 4th UP Forecast | 6.19 |
| 3rd UP Forecast | 5.51 |
| 2nd UP Forecast | 5.09 |
| 1st UP Forecast | 4.67 |
| 1st DOWN Forecast | 3.47 |
| 2nd DOWN Forecast | 3.05 |
| 3rd DOWN Forecast | 2.63 |
| 4th DOWN Forecast | 1.95 |
RLFTF Weekly Forecast
| 4th UP Forecast | 6.94 |
| 3rd UP Forecast | 6.02 |
| 2nd UP Forecast | 5.45 |
| 1st UP Forecast | 4.88 |
| 1st DOWN Forecast | 3.26 |
| 2nd DOWN Forecast | 2.69 |
| 3rd DOWN Forecast | 2.12 |
| 4th DOWN Forecast | 1.20 |
RLFTF Forecast2025
| 4th UP Forecast | 16.56 |
| 3rd UP Forecast | 12.55 |
| 2nd UP Forecast | 10.08 |
| 1st UP Forecast | 7.6 |
| 1st DOWN Forecast | 0.54 |
| 2nd DOWN Forecast | -1.94 |
| 3rd DOWN Forecast | -4.41 |
| 4th DOWN Forecast | -8.42 |
Relief Therapeutics Holding AG ( OTCQB USA Symbol : RLFTF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RLFTF Business Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications is being investigated in two U.S. Phase 2b/3 clinical trials in acute respiratory deficiency due to COVID-19, as well as in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also involved in clinical development of RLF-100 for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG is based in Geneva, Switzerland. Address: BAtiment F2/F3, Geneva, Switzerland, 1202
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service